Taeko Inoue

Taeko Inoue

Auto-generated profile, based on publicly available information

Taeko Inoue

Departments of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2014 in Molecular Neurodegeneration
Verified
Journal Article
Open access
PDF file
HLHongmei Li
Hongmei Li
QGQinxi Guo
Qinxi Guo
TITaeko Inoue
Taeko Inoue
VPVinicia A Polito
Vinicia A Polito
Katsuhiko TabuchiKatsuhiko Tabuchi
Katsuhiko Tabuchi
HZHui Zheng
Hui Zheng
Accumulation and deposition of β-amyloid peptides (Aβ) in the brain is a central event in the pathogenesis of Alzheimer’s disease (AD). Besides the parenchymal pathology, Aβ is known to undergo active transport across the blood–brain barrier and cerebral amyloid angiopathy (CAA) is a prominent feature in the majority of AD. Although impaired cerebral blood flow (CBF) has been implicated in faulty Aβ transport and clearance, and cerebral hypoperfusion can exist in the pre-clinical phase of Alzheimer’s disease (AD), it is still unclear whether it is one of the causal factors for AD pathogenesis, or an early consequence of a multi-factor condition that would lead to AD at late stage. To study the potential interaction between faulty CBF and amyloid accumulation in clinical-relevant situation, we generated a new amyloid precursor protein (APP) knock-in allele that expresses humanized Aβ and a Dutch mutation in addition to Swedish/London mutations and compared this line with an equivalent knock-in line but in the absence of the Dutch mutation, both crossed onto the PS1M146V knock-in background.